Statistics for Advancing T cell-based immunotherapies through targeted engineering with CRISPR-Cas9
Total visits
| views | |
|---|---|
| Advancing T cell-based immunotherapies through targeted engineering with CRISPR-Cas9 | 111 |
Total visits per month
| views | |
|---|---|
| December 2025 | 2 |
| January 2026 | 2 |
| February 2026 | 8 |
| March 2026 | 7 |
| April 2026 | 3 |
| May 2026 | 0 |
| June 2026 | 2 |
File Visits
| views | |
|---|---|
| Carleton_Gillian_PhD_2024.pdf | 37 |
Top country views
| views | |
|---|---|
| Canada | 70 |
| India | 8 |
| United States | 8 |
| Germany | 4 |
| France | 3 |
| United Kingdom | 3 |
| Saudi Arabia | 3 |
| Cyprus | 2 |
| Ecuador | 2 |
| Iran | 2 |
| China | 1 |
| Hong Kong SAR China | 1 |
| Italy | 1 |
| Japan | 1 |
| Singapore | 1 |
| Taiwan | 1 |
Top city views
| views | |
|---|---|
| Victoria (Downtown) | 34 |
| Victoria | 28 |
| Mumbai | 4 |
| New Delhi | 3 |
| Riyadh | 3 |
| Calgary | 2 |
| London | 2 |
| Mont-Saint-Aignan | 2 |
| Nicosia | 2 |
| Regensburg | 2 |
| Tehran | 2 |
| Vancouver (Fairview) | 2 |
| Vancouver (Ubc) | 2 |
| Ann Arbor | 1 |
| Ashburn | 1 |
| Bhopal (Govindpura) | 1 |
| Bushwick | 1 |
| Charlack | 1 |
| Frankfurt am Main | 1 |
| Haidian (Haidian Qu) | 1 |
| Ibarra | 1 |
| Johnston | 1 |
| Ma Liu Shui | 1 |
| Manchester | 1 |
| Munich (Moosach) | 1 |
| Nanterre | 1 |
| Oakland (Pill Hill) | 1 |
| Osaka | 1 |
| Prince George | 1 |
| Queenstown | 1 |
| Quito | 1 |
| San Jose (Downtown San Jose) | 1 |
| Sassacci | 1 |
| Singapore (Downtown Core) | 1 |
| Vernon | 1 |
| Yingge District | 1 |